ABSTRACT -The placenta secures the embryo and fetus to the endometrium and releases a variety of steroid and peptide hormones that convert the physiology of a female to that of a pregnant female. Chemical-induced alteration or deviation of placental function in the maternal and extraembryonic tissue can ultimately lead to pregnancy loss, congenital malformation and fetal death. The 6-mercaptopurine (6-MP), an anti-leukemic drug, is known to produce undesired effects on some organs, then the placenta/embryo toxicity of 6-MP was investigated in pregnant rats given 60 mg/kg with two intraperitoneal injections on gestation days (GD) 11 and 12. The rats were sacrificed and their placentas were collected on GD13 or 15. On GD15 small and limb-defected embryos were found in the 6-MP-treated rats. Placental weights were significantly reduced on GD15, as well as a reduced number of cells was detected in the labyrinth zone with both the labyrinth and basal zones having thinned. Cleaved caspase-3-positive cells increased in number in the labyrinth zone, while in the basal zone, glycogen cells reduced with cytolysis. The number of spongiotrophoblasts and trophoblastic giant cells also increased by 6-MP treatment. The 6-MP-treatment resulted in the increased xanthine oxidase (Xdh) expression in the placenta, which gene is related to the ischemic condition of tissues. These data suggest that apoptosis of the labyrinth zone cells may lead to decreased materno-fetal exchange. Moreover, subsequent ischemia in the placental tissue may occur and induce Xdh expression.
INTRODUCTION
The placenta is composed of a variety of differentiated epithelial cell types (trophoblast) each having specialized functions during pregnancy. The placenta secures the embryo and fetus to the endometrium and releases a variety of steroid and peptide hormones that convert the physiology of a female to that of a pregnant female. It is also responsible for materno-fetal exchange of gases and nutrient requirements during embryonic development, as well as providing a protective barrier to xenobiotics. Placental growth and function affect the biological significance of the maintenance of pregnancy and placental life. Therefore, drug-induced alteration or deviation of placental function in the maternal and extraembryonic tissue can ultimately lead to pregnancy loss, congenital malformation and fetal death.
The 6-mercaptopurine (6-MP), anti-leukemic drug, is an immunosuppressive drug. The 6-MP has been shown to induce embryo-toxic effects, including a reduction in the number of implantation sites and also to have teratogenicity, which includes limb defects, micrognathia, and ventral hernia in rats (Amemiya et al., 1986; Furukawa et al., 2008) . Furthermore, Bragonier et al. (1964) suggested that placental tissues may be more sensitive to 6-MP than the fetus. In addition to producing anomalies in rats, 6-MP and thioguanine cause a decrease in placental weight. And the 6-MP-treated rat placenta showed a disproportionate reduction in thickness of the labyrinth zone with fibrinous degeneration of trophoblasts (Bragonier and Carver, 1968; Shrader et al., 1978) . However, there are few detailed reports about the mechanisms of placental toxicity in 6-MP-exposed rats.
One of the important functions of placenta is maternofetal exchange by gases. Changes of placental organization may affect the materno-fetal exchanges by O 2 /CO 2 . Loss of placental weights and reduction in thickness of the labyrinth zone could induce defective circulation of oxygen to the embryo. Xanthine oxidase (Xdh), which metabolizes xanthine and hypoxanthine to uric acid with production of superoxide and hydrogen peroxide, is an integral mediator of reactive oxygen species (ROS) generation in many settings. With hypoxia and in response to several cytokines, xanthine dehydrogenase/xanthine oxidase (Xo) synthesis increases, and the conversion of the enzyme to the Xo form is enhanced. Reduced organ perfusion and subsequent reperfusion are proposed to result in increased Xo during reduced flow and in subsequent formation of ROS with reperfusion. Therefore, we hypothesized that 6-MP-induced embryo deficit would be due to ischemic condition induced by the compound.
The purpose of this study was to investigate the toxic mechanisms of 6-MP on placenta and embryo development. We examined morphological changes in placenta from rats exposed to 6-MP at 60 mg/kg during gestation days (GDs) 11 to 12. The dose of 60 mg/kg intraperitoneal injection on GD11 and/or 12 was previously reported to have an effect on placentas and embryos in rats (Bragonier and Carver, 1968; Shrader et al., 1978; Furukawa et al., 2008) . Moreover, histological changes in the labyrinth and basal zones thought to be induced ischemic condition. Thus, we examined expression of Xdh, an ischemia-related gene, in the rat placenta.
MATERIALS AND METHODS

Materials
6-Mercaptopurine monohydrate and olive oil were purchased from WAKO chemical, Osaka, Japan. Cleaved caspase-3 (Asp175) antibody was purchased from CST Japan (Cell Signaling Technology Japan, K.K., Tokyo, Japan). Other chemical reagents of the highest grade used in this study were purchased from WAKO chemical, Osaka, Japan.
Animals
A total of 22 pregnant Sprague-Dawley rats, at approximately 9 weeks of age, were purchased from Charles River Laboratories Japan, Inc., Yokohama, Japan. The animals were individually-housed in wire-mesh cages in an air-conditioned room (21 ± 2ºC; humidity, 45-60%; light-cycle, 12 hr/day). Feed and water were available ad libitum.
Experimental design
The experimental design was accepted by the Showa University animal care committee. This study was conducted in compliance with the "Law Concerning the Protection and Control of Animals", "Standards Relating to the Care and Management of Laboratory Animals and Relief of Pain", "Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions" and "Guidelines for Proper Conduct of Animal Experiments". The dose and sampling schedule referred to the protocol of Furukawa et al. (2008) . The day on which the vaginal plug appeared was designated as gestation days (GD) 0. The 6-MP (60 mg/kg) was suspended in olive oil and administered with an intraperitoneal injection on GD 11 and 12. Maternal rats were anesthetized and sacrificed for collecting their placenta tissues, embryos and plasma samples on GD13 or GD15 of pregnancy. Placenta tissues were weighed and half the number of these placentas was used for total RNA extraction and the other half the number of them used as histological samples.
Histopathological and immunohistochemical analysis
Placenta samples were fixed by immersion in 10% buffered formalin for 24 hr. Fixed samples were dehydrated, and embedded in paraffin according to the standard procedure. Paraffin-embedded placenta tissue blocks were then cut into 5 μm-thick sections and mounted on slides, dewaxed and rehydrated. The sections were stained with hematoxylin and eosin (H&E), and immunohistochemical staining was performed using cleaved caspase-3 antibodies and the standard protocol of the diaminobenzidine (DAB) substrate kit for peroxidase (Vector Laboratories, Inc., Burlingame, CA, USA).
Reverse transcription and quantitative real-time PCR
Placentas were isolated from uterus, frozen using liquid nitrogen, and homogenized by a Polytron homogenizer. Total RNA was extracted using the miRNeasy Mini kit (QIAGEN K.K., Tokyo, Japan) according to the manufacturer's procedure. Then the RNA quality and quantity were measured using the NanoDrop ND-1000 (Thermo Fisher Scientific Inc., Waltham, MA, USA).
Two micrograms of total RNA from each sample were used for the RT reaction to generate cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) and random hexamers. Quantitative real-time PCR was performed in triplicate using the TaqMan Gene Expression Master Mix (Applied Biosystems) according to the manufacturer's instructions and using the ABI PRISM 7900 (Applied Biosystems). Xanthine oxidase (Xdh) gene-specific TaqMan Gene Expression Assays (Applied Biosystems) were used (assay ID: Rn00567654_m1). The thermal cycle of the real-time PCR was 95ºC for 10 min, 40 cycles at 95ºC for 15 sec and 60ºC for 60 sec. The expression of mRNA for Xdh was evaluated relative to the expression of a housekeeping gene (Gapdh), and the relative expression calculated using the 2 -ΔΔCT method (Livak and Schmittgen, 2001 ).
Statistical analysis
Data were reported as mean ± S.E. and analyzed by using Student's t-test or Welch's t-test. p < 0.05 was considered to be statistically significant.
RESULTS
Changes in placental weight and embryo development by 6-MP treatment
The placental weight and number of corpora lutea and implantation are shown in Table 1 . The 6-MP administered animals had ascetic fluid and one 6-MP-treated rat was found dead on GD14. The 6-MP-treated rats were not affected as to the number of corpora lutea and implantation, however, the frequency of embryo resorption was increased (data not shown). Placental weights on GD15 were highly statistically significant (p < 0.001) reduced in comparison with the control (Table 1 . and Fig. 1a) . Uterus weights were slightly decreased but not statistically significant (Fig. 1b) and the changes in ovary weights were not also statistically significant in 6-MP-treated animals (Fig. 1c) . Placental weight loss on GD15 had similar results with report of Furukawa et al. (2008) . Macroscopically, the 6-MP-treated placenta was pale (data not shown) and embryos from rats treated with 6-MP were observed to have growth retardation, limb and tail defects (Fig. 1d, left) .
Histopathological evaluation of 6-MP-treated rat placentas
In the 6-MP-treated rat placentas, the labyrinth and the basal zones were thinned and the number of cells was reduced (Fig. 2a) . In the basal zone from rat placentas treated with 6-MP, glycogen cells were reduced and spongiotrophoblasts were increased in comparison with the controls. The thickness of each layer was statistically significant thinned, and the labyrinth zone was dominantly thinned (Fig. 2b) . Glycogen cells were lysed in the basal zone (Fig. 3b) . The 6-MP-treated giant cells were enlarged and the number of the cells increased in comparison with the controls (Figs. 3a and b) .
In the immunohistochemical analysis, the number of caspase-3 positive cells was increased in labyrinth zone of 6-MP-treated placentas in comparison with the controls (Figs. 3c and d) . Basal zone cells were not stained by caspase-3 antibodies under the present experimental conditions (data not shown).
Changes in gene expression of xanthine oxidase in 6-MP-treated rat placentas
In addition to histopathological and morphological changes and reduced weight, the 6-MP-treated placenta was pale in comparison with the control placentas (data not shown). Because of these histological changes, 6-MP treatment may induce decreasing blood flow in the placenta. We thus investigated the expression of an ischemia-related gene, Xdh, in the placenta. Placental total RNAs were performed with Real-time PCR by using TaqMan ® Gene Expression Assays (probe ID; Rn00567654_m1). Each PCR reaction carried out triplicate and relative expression indicated corrected by inter- 6-MP 2 a) 15 30 0.166 ± 0.03*** 32 32 Placental weights were shown by mean ± S.E. of number of placentas. The 6-MP-treated placental weight on GD15 was significantly reduced in comparison with the control. a) One rat was died on two days after 6-MP injection. ***: Significantly different from control at p < 0.001 (Welch's t-test).
nal control gene (Gapdh). 6-MP treatment placentas resulted in increased expression of Xdh to about two-fold on GD13 compared to the control (Fig. 4) . On the other hand, expression of Xdh was not changed on GD15 compared to the control (Fig. 4) .
DISCUSSION
In the present study, administration of 6-MP to pregnant rats decreased placental weights and suppressed embryonic development. Macroscopically, 6-MP-treat- ed placentas were small, thinned, and looked pale. Histologically, the labyrinth and basal zones were thinned. In addition to these previously reported fi ndings, we fi rst observed ischemic-related gene, xanthine oxidase (Xdh), was upregulated in the 6-MP-treated rat placentas. These fi ndings suggest that 6-MP administration to pregnant rats resulted in the reduction of uterine blood fl ow to the placental tissues and nutrient transport to the fetuses. 6-MP is a source of thioguanine nucleotides, which may be incorporated into DNA, yielding abnormal DNA, thus interfering with the function of DNA polymerases, ligases and endonucleases (Platzek et al., 1994; Estlin, 2001 ). Moreover, 6-MP is catalyzed to inhibitors of enzymes that are important in de novo purine synthesis (Estlin, 2001 ). Nucleoside metabolism probably plays an important role in the early post-implantation stages of the placenta, since enzymes of the degradation pathways of purine metabolism are enriched at the materno-fetal interface of mice (Blackburn et al., 1997) , and are highly expressed in human maternally-derived decidual cells and in trophoblast cells at that time (Lupidi et al., 1998) . Thus, it is not surprising that 6-MP, which affects nucleoside metabolism, will adversely affect the placenta. Inhibition of migration and proliferation, and increased apoptosis of other cell types by 6-MP was already observed in the past. Thus, 6-MP may affect embryos indirectly by its placental toxicity although a direct effect of the compound should be investigated in future studies. The 6-MP-induced placental toxicity was observed in both the labyrinth and basal zone cells. While the number of labyrinth zone cells decreased, anti-caspase-3 positive cells increased in the labyrinth zone, indicating the increasing apoptotic activity in labyrinth zone cells. The results are well compatible to the reports where the increasing in apoptotic cells were characterized by pyknosis or karyorrhexis, phagocytosis and cell debris, and positively stained by the TUNEL (TdT-mediated dUTP nick-end labeling) method in the labyrinth zone (Furukawa et al., 2008) . As development of the labyrinth zone is usually active during gestation, the labyrinth zone cells thought to be more affected by 6-MP-induced cytotoxicity than basal zone cells.
In the basal zone, glycogen cells were reduced with cytolysis, whereas spongiotrophoblasts increased. Furukawa et al. reported that periodic acid-Schiff (PAS)-positive material was still detected on GD15 in the spongiotrophoblasts. The 6-MP induces a delay in the developmental process in the basal zone (Furukawa et al., 2008) .
Furthermore, the number of trophoblastic giant cells (TGCs) was increased in the basal zone of 6-MP-treated placenta. TGCs are thought to play important roles for embryo implantation, establishment of the materno-fetal interface and maternal adaptations to pregnancy based on their obvious invasive and endocrine properties. In general, the TGCs in the rat placenta have 6 to 7 cell layers on GD12, and developing placenta has 3 to 4 cell layers of TGCs on GD17 (Dickson and Bulmer, 1960) . TGCs produce progesterone (Chan and Leathem, 1975) and placental lactogen (Soares et al., 1991) . Increasing the number of TGCs seen in this study may cause the changes of hormonal regulation. However, the toxicological signifi cance of the increased number of TGCs produced by 6-MP remains to be determined.
Placental growth restriction and functional defects are directly associated with intrauterine growth retardation (IUGR) and fetal mortality (Watson and Cross, 2005) . It has been known that some toxicants, such as ethylnitrosourea (ENU) (Katayama et al., 2002) , 1-β-D-arabinofuranosylcytosine (Ara-C) (Yamauchi et al., 2003) , busulfan (Furukawa et al., 2007) , T-2 toxin (Rousseaux and Schiefer, 1987) , and 5-azacytidine (Hossain et al., 1995) , induce small placenta and IUGR with embryonic/fetal death or malformations in rodents. Moreover, small placenta and fetal growth retardation associated with not only chemical toxicity, but also uteroplacental ischemia in rat models of IUGR. Intra-uterine administration of neuromuscular blocking agents affected placental and fetal body weight and size of the rat, and the reduction of placental blood fl ow caused their growth retardation (Shoro, 1981) . Another experimental growth retardation in rat model produced decreasing fetal weights and increasing fetal deaths with the occlusion of uterine horn circulation (Tanaka et al., 1994) . Thus, ischemic condition in placentas due to the reduction of blood fl ow would affect embryos. In this study, the gene expression of Xdh was increased in 6-MP-treated rat placentas. Ischemic conditions induce the expression of Xdh in vitro (Hassoun et al., 1994) . If this same situation occurs in vivo, increased Xdh expression would further increase ROS and damage to the cells with ROS generation in the placenta. The 6-MP may cause ischemia in the placental tissues with small placenta and affect fetal growth retardation.
Xdh is a cytoplasmic enzyme involved in the oxidation of endogenous substrates such as purines and pyrimidines, as well as the exogenous thiopurines. Xdh activity is particularly high in the intestinal mucosa and liver, resulting in a substantial reduction of 6-MP bioavailability and in the lower levels of the active 6-thioguanine (Parks and Granger, 1986 ). Xdh catalyses 6-MP, fi rst to 8-hydroxymercpatopurine and subsequently to 6-thiouric acid (Zimm et al., 1983) . Upregulation of Xdh observed in 6-MP-treated rats may have some effects on the metabolism of the drug in the placenta. Furthermore, recent data indicate that Xdh plays an important role in infl am- Fig. 4 . Upregulated gene expression of xanthine oxidase in the 6-MP-treated rat placenta. Placental total RNAs were extracted and reverse-transcribed to cDNA. TaqMan® Gene Expression Assays (Assay ID: Rn00567654_m1) was used for real-time PCR. Expression of xanthine oxidase was increased in the 6-MP-treated GD13 placenta. Each data was shown by mean ± S.E. of three experiments were each point was done in triplicate.
matory diseases and various forms of tissue and vascular injuries (Pacher et al., 2006) . In kidney epithelial cells, an increased Xdh gene expression has been reported following exposure to a number of inflammatory cytokines, including tumor necrosis factor-α, interferon-γ, interleukin-1 and interleukin-6 (Pritsos, 2000) . It has been suggested that the increased expression of Xdh may play an immunomodulatory and anti-viral role elicited by these cytokines (Pritsos, 2000) . Considering these findings, further study will be required to explore cytokine expressions and their roles in the intoxicated placenta as shown in this study.
In conclusion, we confirmed the 6-MP-induced placental-and embryo-toxicity by histopathological and immunohistochemical analysis in this study. Placental weight was significantly reduced by 6-MP treatment on GD15. Macroscopically, placentas were pale and embryos had defective tails and limbs. Histologically, the number of cells in the labyrinth zone reduced and cleaved caspase-3 positive cells increased. The number of glycogen cells was reduced with cytolysis in the basal zone, while the number of TGCs increased with the abnormal growth of the placenta. We first observed induction of the Xdh gene expression in the 6-MP-treated placenta. The present findings suggest that rats treated with 6-MP induced placental toxicity with apoptosis and ischemia, and the latter induces defective circulation of nutrition, gas and waste.
